Medical Director, Weight Wellness Program; Associate Professor of Internal Medicine; Division of Endocrinology
UT Southwestern Medical Center
Dallas, Texas, United States
Jaime Almandoz, MD, MBA, MRCPI, FTOS is an Associate Professor of Internal Medicine and Medical Director of the Weight Wellness Obesity Medicine Program at the University of Texas Southwestern Medical Center. He is board-certified in Endocrinology and Internal Medicine and a diplomate of the American Board of Obesity Medicine (ABOM).
Dr. Almandoz earned his medical degree from the Royal College of Surgeons in Ireland, completed his Internal Medicine residency and Endocrinology fellowship at the Mayo Clinic, and pursued a fellowship in Nutrition and Metabolic Diseases at UT Southwestern. He currently serves on the Board of Directors for the ABOM and as Vice Chair of the Nutrition and Obesity Disease State Network for the American Association of Clinical Endocrinology. His clinical and research interests include interdisciplinary weight management programs, post-bariatric weight recurrence, and disparities in obesity care.
Sunday, June 1, 2025
2:00 PM – 3:30 PM ET
Disclosure(s): ABBVIE: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing)
Boehringer Ingelheim: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing)
Eli Lilly: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing)
Nestlé: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing)
Novo Nordisk: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing)
WAVE LIFE SCIENCES: Advisory Committee/Board Member (Terminated); Consultant (Terminated)
Meeting the Nutritional Needs of Patients on Anti-Obesity Medications: What’s New?
Sunday, June 1, 2025
2:05 PM – 2:50 PM ET
Disclosure(s): ABBVIE: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing)
Boehringer Ingelheim: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing)
Eli Lilly: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing)
Nestlé: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing)
Novo Nordisk: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing)
WAVE LIFE SCIENCES: Advisory Committee/Board Member (Terminated); Consultant (Terminated)
Sunday, June 1, 2025
2:50 PM – 3:05 PM ET
Disclosure(s): ABBVIE: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing)
Boehringer Ingelheim: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing)
Eli Lilly: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing)
Nestlé: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing)
Novo Nordisk: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing)
WAVE LIFE SCIENCES: Advisory Committee/Board Member (Terminated); Consultant (Terminated)